PS
ONC

Principal Securities’s BeOne Medicines Ltd ONC Stock Holding History

Principal Securities’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$34.1K – 3685
2025
Q3 		$34.1K Buy
100
+16
+19% +$4.86K ﹤0.01% 2141
2025
Q2 		$20.3K Sell
84
-15
-15% -$3.68K ﹤0.01% 2305
2025
Q1 		$18.3K Hold
99
– – ﹤0.01% 2248
2024
Q4 		$18.3K Buy
99
+9
+10% +$1.84K ﹤0.01% 2246
2024
Q3 		$20.2K Sell
90
-5
-5% -$900 ﹤0.01% 2120
2024
Q2 		$13.6K Buy
95
+39
+70% +$6.01K ﹤0.01% 2259
2024
Q1 		$8.76K Hold
56
– – ﹤0.01% 2395
2023
Q4 		$10.1K Buy
+56
New +$10.1K ﹤0.01% 2235

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Principal Securities's ONC Position: Q4 2025 in Review

Principal Securities sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 100 shares — an estimated $34.1K sold.

Principal Securities first reported a position in ONC in Q4 2023 and held it in 8 quarters. The position peaked at $34.1K in Q3 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Principal Securities reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 100 BeOne Medicines Ltd shares in Q4 2025, an estimated $34.1K.
  • Principal Securities first reported a position in BeOne Medicines Ltd in Q4 2023 and held it in 8 quarters.
  • Principal Securities's BeOne Medicines Ltd position peaked at $34.1K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.